New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
Splitsvilla X5 Winner Akriti Negi's BF Anshumat Srivastava Calls Out Trolling Against Her Amid Breakup Rumours: 'Tearing Someone Down For Clicks...'
Pakistan Pacer Shaheen Afridi Ruled Out Of BBL 2025 Due To Injury Ahead Of ICC T20 World Cup 2026 Squad Selection Deadline
Thane New Year 2026: Police Deploy 739 Personnel, Set Up 54 Checkpoints To Curb Drunk Driving And Traffic Violations
Uttarakhand Ranks 2nd Nationwide In Mining Reforms, Earns ₹200 Crore Incentive
